Drugs / Platelet-Rich Plasma (PRP) Injections
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07277998 Comparator | Mar → Jul 2026 overdue | oral submucous fibrosis | Karachi Medical and Dental College | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet-Rich Plasma (PRP) Injections | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07277998 ↗ |
| Known as | PRP | “Autologous Platelet-rich plasma (PRP) injected intralesionally at standard volume for Oral submucous fibrosis (OSF) treatment, administered every alternate week” NCT07277998 ↗ |
| Modality | Other / unclassified | “Autologous Platelet-rich plasma (PRP) injected intralesionally at standard volume” NCT07277998 ↗ |
| Route | Other | “Autologous Platelet-rich plasma (PRP) injected intralesionally” NCT07277998 ↗ |